Latest Regulatory News

Page 615 of 619
Bounty Oil & Gas NL has been notified of the refusal of its Joint Venture Applications for the PEP 11 permit, which remains valid for two months. The company is now considering a legal challenge to this decision.
Victor Sage
Victor Sage
20 Jan 2025
Xanadu Mines has lodged a comprehensive NI 43-101 technical report for its Kharmagtai Copper-Gold Project, revealing key differences in production and economic outcomes compared to earlier ASX disclosures due to regulatory standards.
Maxwell Dee
Maxwell Dee
20 Jan 2025
PolyNovo Limited reports a robust 22.8% revenue increase in 1H FY25, driven by strong U.S. and international sales growth and progressing FDA approval efforts for its NovoSorb platform.
Ada Torres
Ada Torres
17 Jan 2025
Wellard Limited has disclosed the binding sale of its last livestock vessel, the M/V Ocean Drover, for US$50 million, with plans to return the net proceeds to shareholders pending approval.
Ada Torres
Ada Torres
17 Jan 2025
Immuron Limited reports a striking 70% quarter-on-quarter increase in Travelan® sales, driven by expanded pharmacy distribution in Australia and North America.
Victor Sage
Victor Sage
17 Jan 2025
Beam Dental Bidco Pty Ltd has extended its off-market takeover offer for Pacific Smiles Group Limited, pushing the closing date to January 30, 2025. This extension signals ongoing negotiations and a potentially protracted acquisition process.
Ada Torres
Ada Torres
16 Jan 2025
Artrya Limited has responded to an ASX price query following a notable surge in its share price, confirming no undisclosed information and adherence to continuous disclosure rules.
Ada Torres
Ada Torres
16 Jan 2025
Visioneering Technologies reports promising interim results from its PROTECT trial, showing significant control of myopia progression in children using NaturalVue® Multifocal lenses.
Ada Torres
Ada Torres
16 Jan 2025
Memphasys Limited has secured a major scientific endorsement for its RoXsta™ antioxidant profiling system, positioning the technology for expanded clinical and agricultural applications.
Ada Torres
Ada Torres
16 Jan 2025
Dimerix has reached a key milestone by enrolling the first paediatric patient aged 12-17 in its ACTION3 Phase 3 trial for DMX-200, advancing its potential treatment for childhood FSGS kidney disease.
Victor Sage
Victor Sage
16 Jan 2025
Rio Tinto's Q4 2024 production results reflect steady operational performance with record bauxite output and significant progress on key growth projects like Oyu Tolgoi and Rincon lithium expansion.
Maxwell Dee
Maxwell Dee
16 Jan 2025
Magnetic Resources has significantly increased the gold resource estimate at its Lady Julie Gold Project to 1.75 million ounces, advancing plans for concurrent underground mining and an expanded processing plant.
Maxwell Dee
Maxwell Dee
16 Jan 2025